HealthNotableSingle-sourceDeveloping
5.2
First patient receives gene-edited insulin-producing cell transplant without immunosuppression
Dagens NyheterLO·SE·about 17 hours ago
Researchers at Tel Aviv University are nearing the first human clinical trial of a spinal cord implant designed to restore mobility in paralyzed patients. While the technology aims to enable standing and walking, the timeline for the initial procedure and the specific patient criteria remain unconfirmed.
Locations
Entities